R35ES031693
Project Grant
Overview
Grant Description
Epitranscriptomic Mechanism of Environmental Stress Response and Tumorigenesis - Abstract
All organisms, including humans, are constantly exposed to various environmental agents that cause damage to the DNA as well as other biomolecules, and thus threaten genomic integrity and cellular homeostasis, leading to the development of various diseases such as cancer.
During the past few years, supported by NIEHS funding, my lab has carried out several screening studies, leading to exciting discoveries on the role of RNA modifications in DNA repair, cellular homeostasis, and tumorigenesis induced by UV irradiation and arsenic, two known carcinogenic agents. These results focus particularly on the most abundant internal mRNA methylation, N6-methyladenosine (m6A) mRNA methylation.
However, the major challenge is that how environmental agents interact with the epitranscriptome in disease pathogenesis remains poorly understood. Based on the discoveries made in our published work and our unpublished findings, I propose to test this overarching hypothesis: environmental insults dysregulate the epitranscriptomic machinery and thus impair genomic integrity and cellular homeostasis, leading to tumorigenesis.
The focus of my R35 application is to determine the epitranscriptomic mechanism of environmental stress response and tumorigenesis in biochemical systems, cells, and mouse xenograft/orthotopic/genetic tumor models. As the research program evolves, we will then establish the relevance of these discoveries in human samples. Furthermore, we will also expand our investigation to explore how RNA modifications are modulated by other environmental carcinogenic agents, in skin cells and in epithelial cells of other tissue origins that are targeted by these carcinogens.
We will employ the novel m6A methylome sequencing technology developed by our collaborator's lab, as well as other sequencing technologies to map the environmental epitranscriptome. In addition, we will continue to create new genetic mouse models to investigate the role of RNA modifications in environmental tumorigenesis.
My broad research program will pursue the following goals: (I) establish the mechanism by which m6A RNA methylation regulates tumorigenesis following UVB radiation and arsenic exposure; (II) discover new enzymes that regulate m6A mRNA methylation in environmental stress response and tumorigenesis; (III) explore the roles of other RNA modifications in environmental stress response and tumorigenesis; and (IV) identify new molecules that modulate RNA modifications as probes/therapeutics.
The resultant discoveries can vastly expand our knowledge to further establish the role of environmental epitranscriptomics in stress response and cancer, and open up new opportunities to develop new epitranscriptomics-based probes/therapeutics to improve prevention and therapy for cancer as well as other diseases.
All organisms, including humans, are constantly exposed to various environmental agents that cause damage to the DNA as well as other biomolecules, and thus threaten genomic integrity and cellular homeostasis, leading to the development of various diseases such as cancer.
During the past few years, supported by NIEHS funding, my lab has carried out several screening studies, leading to exciting discoveries on the role of RNA modifications in DNA repair, cellular homeostasis, and tumorigenesis induced by UV irradiation and arsenic, two known carcinogenic agents. These results focus particularly on the most abundant internal mRNA methylation, N6-methyladenosine (m6A) mRNA methylation.
However, the major challenge is that how environmental agents interact with the epitranscriptome in disease pathogenesis remains poorly understood. Based on the discoveries made in our published work and our unpublished findings, I propose to test this overarching hypothesis: environmental insults dysregulate the epitranscriptomic machinery and thus impair genomic integrity and cellular homeostasis, leading to tumorigenesis.
The focus of my R35 application is to determine the epitranscriptomic mechanism of environmental stress response and tumorigenesis in biochemical systems, cells, and mouse xenograft/orthotopic/genetic tumor models. As the research program evolves, we will then establish the relevance of these discoveries in human samples. Furthermore, we will also expand our investigation to explore how RNA modifications are modulated by other environmental carcinogenic agents, in skin cells and in epithelial cells of other tissue origins that are targeted by these carcinogens.
We will employ the novel m6A methylome sequencing technology developed by our collaborator's lab, as well as other sequencing technologies to map the environmental epitranscriptome. In addition, we will continue to create new genetic mouse models to investigate the role of RNA modifications in environmental tumorigenesis.
My broad research program will pursue the following goals: (I) establish the mechanism by which m6A RNA methylation regulates tumorigenesis following UVB radiation and arsenic exposure; (II) discover new enzymes that regulate m6A mRNA methylation in environmental stress response and tumorigenesis; (III) explore the roles of other RNA modifications in environmental stress response and tumorigenesis; and (IV) identify new molecules that modulate RNA modifications as probes/therapeutics.
The resultant discoveries can vastly expand our knowledge to further establish the role of environmental epitranscriptomics in stress response and cancer, and open up new opportunities to develop new epitranscriptomics-based probes/therapeutics to improve prevention and therapy for cancer as well as other diseases.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Chicago,
Illinois
606375418
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 691% from $533,858 to $4,223,858.
University Of Chicago was awarded
Environmental Epitranscriptomic Mechanism in Tumorigenesis
Project Grant R35ES031693
worth $4,223,858
from the National Institute of Environmental Health Sciences in August 2023 with work to be completed primarily in Chicago Illinois United States.
The grant
has a duration of 7 years 9 months and
was awarded through assistance program 93.113 Environmental Health.
The Project Grant was awarded through grant opportunity Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
8/1/23
Start Date
5/31/31
End Date
Funding Split
$4.2M
Federal Obligation
$0.0
Non-Federal Obligation
$4.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to R35ES031693
Additional Detail
Award ID FAIN
R35ES031693
SAI Number
R35ES031693-2293947094
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NV00 NIH National Institute of Enviromental Health Sciences
Funding Office
75NV00 NIH National Institute of Enviromental Health Sciences
Awardee UEI
ZUE9HKT2CLC9
Awardee CAGE
5E688
Performance District
IL-01
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Environmental Health Sciences, National Institutes of Health, Health and Human Services (075-0862) | Health research and training | Grants, subsidies, and contributions (41.0) | $533,858 | 100% |
Modified: 6/22/26